https://scholars.mssm.edu/en/publications/phase-ii-study-of-selumetinib-azd6244-arry-142886-plus-irinotecan-2/
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in...
https://www.rxlane.com/product-tag/selumetinib-uses
Selumetinib uses
selumetinibuses
https://eprints.whiterose.ac.uk/id/eprint/168531/
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine...
the potentialclinical benefitinvestigating
https://www.synzeal.com/br/selumetinib-impurity-25-3
Selumetinib Impurity 25 | CAS No. 1415559-53-3 | | SynZeal
Buy high-quality Selumetinib Impurity 25 from SynZeal. Selumetinib Impurity 25 Reference Standard is supplied with COA and analytical data. CAS No....
selumetinibimpuritycas
https://pubmed.ncbi.nlm.nih.gov/26912134/
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or...
The recommended dose of selumetinib when combined with CisGem was 75 mg bd. Translational studies are underway to identify biomarkers that may predict outcome...